Back to the search results

St. Antonius-Hospital Gronau GmbH

Möllenweg 22
48599 Gronau

Phone: 02562-915-0
Fax: 02562-915-1555
Mail: ed.uanorg-suinotna-ts@suah

http://www.st-antonius-gronau.de

Basic information

Number of beds: 266
Number of specialist departments: 16

Number of inpatient cases: 12.285
Number of outpatient cases: 29.528

Hospital owners: St. Antonius-Hospital Gronau GmbH
Type of provider: freigemeinnützig

Specialist departments

Services

Quality

External comparative quality assurance

Further information

External quality assurance according to state law
No participation

External quality assurance according to the DMP

Asthma bronchiale

Die Ziele der DMP Asthma bronchiale sind u.a.: - Vermeidung notfallmäßiger stationärer Behandlungen von Patienten mit Asthma bronchiale - Erhöhung des Anteils der Patienten mit inhalativen Glukokortikosteroiden als Bestandteil der Dauermedikation - Erhöhung des Anteils der Patienten, die bei Beginn einer notwendigen Dauertherapie mit oralen Steroiden zum Facharzt überwiesen werden - Erhöhung der Rate verordneter und durchgeführter Schulungen

Participation in other external comparative quality assurance procedures

Implementation of the minimum quantity agreement

Treatment area

Knee joint total endoprostheses

Quantity performed	146
Exception?	No exception

Minimum quantities forecast

Knee joint total endoprostheses

Overall result forecast presentation:	yes
Quantity performed reporting year:	146
Quantity forecast year:	156
Examination by state associations?	yes
Exemption?	yes
Result of the examination by the federal state authorities?	yes
Transitional arrangement?	no

Implementation of resolutions of the Federal Joint Committee on quality assurance (G-BA)
No participation

Compliance with staffing requirements

Clarifying chat completed: no
Clarifying chat not completed: no
No participation in clarifying chat: no
Notification of non-fulfilment of nursing care not made: no

Further training
pursuant to Article 136b, para. 1, sentence 1, no. 1 of the SGB

Number	Group
63	Medical specialists (m/f) , psychological psychotherapists (m/f) and child and adolescent psychotherapists (m/f) who are subject to the obligation to undergo further training*
49	Number of medical specialists (m/f) from no. 1 who have completed a five-year period of further training and are therefore subject to the obligation to provide evidence
44	Number of those persons from no. 2 who have provided proof of further training according to Article 3 of the G-BA regulations

* according to the “Provisions of the Joint Federal Committee for the Further Training of Medical Specialists (m/f), Psychological Psychotherapists (m/f) and Child and Adolescent Psychotherapists (m/f) in Hospitals”

General information

Protection concept against (sexual) violence against children and young people

Advice on prevention and intervention in cases of violence and abuse

According to Section 4 (2) of the Quality Management Guideline, facilities must provide for the prevention of and intervention in cases of violence and abuse as part of their internal quality management. The aim is to prevent, recognise and respond appropriately to abuse and violence, particularly against vulnerable patient groups such as children and adolescents or people in need of help, and also to prevent it within the facility. The respective procedure is aligned with the size of the facility, the range of services and the patients in order to define customised solutions for sensitising the teams as well as other suitable preventative and interventional measures. These may include information materials, contact addresses, training/education, codes of conduct, recommendations for action/intervention plans or comprehensive protection concepts.

Is a protection concept in place? Yes
No care for children and young people

Commentary on the protection concept

Gemäß § 4 Absatz 2 in Verbindung mit Teil B Abschnitt I § 1 der Qualitätsmanagement-Richtlinie haben sich Einrichtungen, die Kinder und Jugendliche versorgen, gezielt mit der Prävention von und Intervention bei (sexueller) Gewalt und Missbrauch bei Kindern und Jugendlichen zu befassen (Risiko- und Gefährdungsanalyse) und – der Größe und Organisationsform der Einrichtung entsprechend – konkrete Schritte und Maßnahmen abzuleiten (Schutzkonzept). In diesem Abschnitt geben Krankenhäuser, die Kinder und Jugendliche versorgen, an, ob sie gemäß § 4 Absatz 2 in Verbindung mit Teil B Abschnitt I § 1 der Qualitätsmanagement-Richtlinie ein Schutzkonzept gegen (sexuelle) Gewalt bei Kindern und Jugendlichen aufweisen.

Drug therapy safety

Steering committee

Drug commission

Training of employees on AMTS related topics

Availability of appropriate, topic-specific informational materials for patients on AMTS e.g. for chronic diseases, for high-risk drugs, for children

Use of standardised forms for drug medical history

Risiko- und Qualitätspolitik VA_00136 Dokumentenlenkung VA_00496

26.05.2021

Electronic support for the admission and anamnesis process (e.g. import of patient master data or medication plans, use of a drug knowledge database, input screen for drugs or anamnesis information)

Process description for an optimal medication process (e.g. drug anamnesis – prescription – patient information – drug delivery – drug application – documentation – therapy monitoring – result evaluation)

Risiko- und Qualitätspolitik VA_00136 Dokumentenlenkung VA_00496

26.05.2021

SOP on good prescription practices

Risiko- und Qualitätspolitik VA_00136 Dokumentenlenkung VA_00496

26.05.2021

Possibility of electronic prescription i.e. structured entry of active substances (or name of the preparation), form, dose, dose frequency (e.g. in the HIS, in prescription software)

Provision of one or more electronic drug information systems (e.g. Lauer-Taxe®, ifap klinikCenter®, Gelbe Liste®, Fachinfo-Service®)

Concepts for ensuring the error-free preparation of medications

Bereitstellung einer geeigneten Infrastruktur zur Sicherstellung einer fehlerfreien Zubereitung
Zubereitung durch pharmazeutisches Personal
Anwendung von gebrauchsfertigen Arzneimitteln bzw. Zubereitungen

Electronic support for the supply of patients with drugs

Vorhandensein von elektronischen Systemen zur Entscheidungsunterstützung (z.B. Meona®, Rpdoc®, AIDKlinik®, ID Medics® bzw. ID Diacos® Pharma)

Electronic documentation of the administration of drugs

Measures to minimise medication errors

Fallbesprechungen
Maßnahmen zur Vermeidung von Arzneimittelverwechslung
Spezielle AMTS-Visiten (z. B. pharmazeutische Visiten, antibiotic stewardship, Ernährung)
Teilnahme an einem einrichtungsübergreifenden Fehlermeldesystem (siehe Kapitel 12.2.3.2)

Measures to ensure seamless drug therapy after discharge

Aushändigung von arzneimittelbezogenen Informationen für die Weiterbehandlung und Anschlussversorgung der Patientin oder des Patienten im Rahmen eines (ggf. vorläufigen) Entlassbriefs
Aushändigung von Patienteninformationen zur Umsetzung von Therapieempfehlungen
Aushändigung des Medikationsplans
bei Bedarf Arzneimittel-Mitgabe oder Ausstellung von Entlassrezepten

Instruments and measures

The instruments and measures to promote drug therapy safety are presented with a focus on the typical procedures of the medication process in inpatient patient care. A special feature of the medication process in the inpatient environment is the transition management during admission and discharge. The instruments and measures listed below address structural elements, e.g. special IT equipment and work materials, as well as process aspects, such as work descriptions for particularly risky process steps or concepts for securing typical risk situations . In addition, proven measures to avoid or learn from medication errors can be specified. The hospital presents here which aspects it has already dealt with and which measures it has specifically implemented. The following aspects can be presented, if necessary using free text fields:
- Admission to hospital, including anamnesis
; Instruments and measures are presented for determining the old medication (drug history), the subsequent clinical assessment and the switch to the medication available in the hospital (house list), as well as for documenting both the patient's original medication and that for hospital treatment adapted medication.
- Medication process in the hospital
In this context, the following sub-processes are assumed as examples: drug history - prescription - patient information - drug delivery - drug use - documentation - therapy monitoring - result assessment. Instruments and measures for safe medication prescription can be presented, e.g. B. in terms of readability, clarity and completeness of the documentation, but also in terms of area of application, effectiveness, benefit-risk ratio, tolerability (including potential contraindications, interactions, etc.) and resource considerations. Information can also be provided to support reliable medication ordering, delivery and use or administration.
- Discharge
In particular, the measures taken by hospitals can be presented to ensure that information on drug therapy is structured and passed on to doctors and physicians providing further treatment, as well as the appropriate provision of patients with drug information, medication plans and medications. Drug prescriptions are made.

AMTS is the totality of measures to ensure an optimal medication process with the aim of reducing medication errors and thus avoidable risks for patients during drug therapy. A prerequisite for the successful implementation of these measures is that AMTS is practised as an integral part of daily routine in an interdisciplinary and multi-professional approach.

Special instrument-based equipment

Research & teaching

Job

FL01 - Lectureships / teaching posts at colleges and universities

Explanation

U.a. Lehrauftrag an der MHH Hannover (Klinik für Urologie, Kinderurologie und urologische Onkologie)

FL03 - Student training (clinical traineeship / internship year)

Explanation

Famulaturen/ Praktisches Jahr von Studenten der Humanmedizin in allen Abteilungen des St. Antonius-Hospitals

FL04 - Project-related cooperation with colleges and universities

Explanation

Projektbezogene Zusammenarbeit mit den benachbarten Hochschulen in Münster oder Enschede, gemeinsame Betreuung von Bachelorarbeiten

FL06 - Participation in multi-centre phase III/IV studies

Explanation

Die Teilnahme an Nationalen sowie Internationalen Phase III/IV-Studien gehört zum Aufgabenbereich des Studienzentrums. Hierbei handelt es sich um AMG-, wie auch MPG Studien. Die PROTEUS-Studie, ist eine Phase 3 Studie seit 2020.

FL07 - Initiation and management of uni-centric/multi-centric clinical/scientific studies

Explanation

Das Studienzentrum konzipiert und realisiert klinische Studien nach international gültigen Standards. Dies umfasst die qualifizierte Umsetzung einzelner Bereiche der Planung, Durchführung und Auswertung klinischer Studien.

FL08 - Editors of scientific journals/textbooks

Explanation

Im Rahmen von Projekten erfolgte die Publikation und Präsentation diverser Themen national und international.

FL09 - Doctoral supervision

Explanation

Die wiederholte Betreuung von Doktoranden ist uns ein wichtiges Anliegen zur Nachwuchsförderung. Schulungszentrum für roboterassistierte Chirurgie.

FL05 - Participation in multi-centre Phase I/II studies

Explanation

NIAGARA-Studie in den Jahren 2019 - 2020

Training

Training in other healing professions

HB01 - Nurse and health care worker (m/f)

Comment

Der St. Antonius-Hospital Gronau GmbH ist seit über 30 Jahren eine Gesundheits- und Krankenpflegeschule angeschlossen, in der etwa 100 SchülerInnen in 3 Jahrgängen/ 4 Kurse ausgebildet werden.

HB07 - Surgical technical assistant (m/f)